Summary
The effects of tolbutamide on insulin release, 45Ca2+ uptake and 86Rb+ efflux were studied in isolated rat islets. At a low glucose concentration (75 mg/dl), tolbutamide (20–500 μg/ml) produced a rapid, dose-dependent increase in insulin release from perifused islets. After 30–40 min however, the rate of secretion as well as the potentiating effect of theophylline were inversely related to the concentration of sulphonylurea. The monophasic release of insulin triggered by tolbutamide (100 μg/ml) at low glucose could be evoked again by removing and reintroducing the drug, or by temporarily withdrawing calcium or adding cobalt to the medium. Tolbutamide (20 μg/ml) accelerated and potentiated the biphasic insulin release in response to a secondary stimulation by glucose (150 mg/dl). By contrast, 100 μg/ml tolbutamide reduced the releasing effect of glucose to a slow increase in secretion rates. Theophylline normalized the second phase of release, but did not restore the rapid phase. Tolbutamide stimulated 45Ca2+ influx (2 min-uptake) in islet cells; this effect was maximum immediately after addition of the drug and decreased later on, exhibiting a monophasic pattern. Glucose stimulation of Ca2+ uptake (5 min) was reduced in the presence of 100 μg/ml tolbutamide. At a low glucose concentration, tolbutamide reversibly reduced 86Rb+ efflux (tracer of K+) from islet cells, without altering the further inhibition of this efflux by a later glucose increase. It is suggested that tolbutamide depolarizes B cells partially by reducing their K+ permeability. This depolarization leads to opening of voltagedependent calcium channels and the resulting Ca2+ influx triggers insulin release. The important and maintained depolarization by high concentrations of tolbutamide may secondarily inactivate these channels and cause a decrease in Ca2+ influx. This could explain the monophasic release of insulin and the refractoriness of B cells to subsequent glucose stimulation.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
Loubatières A (1957) The hypoglycemic sulfonamides: history and development of the problem from 1942 to 1945. Ann N Y Acad Sci 71: 4–11
Yalow R S, Black H, Villazon J, Berson S A (1960) Comparison of plasma insulin levels following administration of tolbutamide and glucose. Diabetes 9: 356–362
Seltzer H S (1962) Quantitative effects of glucose, sulfonylureas, salicylate, and indole-3-acetic acid on the secretion of insulin activity into pancreatic venous blood. J Clin Invest 41: 289–300
Bouman P R, Goorenstroom J H (1961) Stimulation by carbutamide and tolbutamide of insulin release from rat pancreas in vitro. Metabolism 10: 1095–1099
Grodsky G M, Schmid F G, Manning M, Fanska R (1973) Comparison of the independent and interrelated effects of glucose and sulfonylureas on insulin release in the perfused pancreas. In: Okita G T, Acheson G M (eds) Pharmacology and the future of man: Proc. 5th Int. Congr. Pharmacology. Vol. 3: Problems of therapy. Karger, Basel, p 230–238
Hellman B, Täljedal I-B (1975) Effects of sulfonylurea derivatives on pancreatic B cells. In: Hasselblatt A, von Bruchausen F (eds) Insulin II. Springer, Berlin Heidelberg New York, p 175–194
Loubatières A (1977) Effects of sulfonylureas on the pancreas. In: Volk B W, Wellmann K E (eds) The diabetic pancreas. Baillière Tindall, London, p 489–515
Grodsky G M, Epstein G H, Fanska R D, Karam J H (1977) Pancreatic action of the sulfonylureas. Fed Proc 36: 2714–2719
Sheldon J, Taylor K W, Anderson J (1965) The effects of long term acetohexamide treatment on pancreatic islet cell function in maturity-onset diabetes. Metabolism 15: 874–883
Reaven G, Dray J (1967) Effect of chlorpropamide on serum glucose and immunoreactive insulin concentrations in patients with maturity-onset diabetes. Diabetes 15: 487–492
Chu P-C, Conway J J, Krouse H A, Goodner C J (1968) The pattern of response of plasma insulin and glucose to meals and fasting during chlorpropamide therapy. Ann Intern Med 68: 757–769
Sussman K E, Stjernholm M, Vaughan G D (1967) Tolbutamide and its effect upon insulin secretion in the isolated perfused rat pancreas. In: Butterfield W J H, von Westering W (eds) Tolbutamide after ten years. Excerpta Medica, Amsterdam, p 22–33
Sodoyez J-C, Sodoyez-Goffaux F, Dunbar J C, Foa P P (1970) Reduction in the activity of the pancreatic islets induced in normal rodents by prolonged treatment with derivatives of sulfonylurea. Diabetes 19: 603–609
Dunbar J C, Foa P P (1974) An inhibitory effect of tolbutamide and glibenclamide (glyburide) on the pancreatic islets of normal animals. Diabetologia 10: 27–35
Schauder P, Arends J, Frerichs H (1977) Onset and reversibility of changes in secretory function and composition of isolated rat pancreatic islets following long-term administration of high and low tolbutamide doses. Metabolism 26: 9–15
Kuo W-N, Hodgins D S, Kuo J F (1973) Adenylate cyclase in islets of Langerhans. Isolation of islets and regulation of adenylate cyclase activity by various hormones and agents. J Biol Chem 248: 2705–2711
Henquin J C, Lambert A E (1975) Cobalt inhibition of insulin secretion and calcium uptake by isolated rat islets. Am I Physiol 228: 1669–1677
Ashcroft S J H, Weerasinghe L C C, Bassett J M, Randle P J (1972) The pentose cycle and insulin release in mouse pancreatic islets. Biochem J 126: 525–532
Henquin I C, Lambert A E (1976) Bicarbonate modulation of glucose-induced biphasic insulin release by rat islets. Am J Physiol 231: 713–721
Henquin J C (1977) Tetraethylammonium potentiation of insulin release and inhibition of rubidium efflux in pancreatic islets. Biochem Biophys Res Commun 77: 551–556
Henquin J C (1978) D-glucose inhibits potassium efflux from pancreatic islet cells. Nature 271: 271–273
Hellman B, Sehlin J, Täljedal I-B (1971) Evidence for mediated transport of glucose in mammalian pancreatic B cells. Biochim Biophys Acta 241: 147–154
Hellman B, Sehlin J, Täljedal I-B (1971) The pancreatic B-cell recognition of insulin secretagogues. II. Site of action of tolbutamide. Biochem Biophys Res Commun 45: 1384–1388
Hellman B, Sehlin J, Täljedal I-B (1973) The pancreatic B-cell recognition of insulin secretagogues. IV. Islet uptake of sulfonylurea. Diabetologia 9: 210–216
Matthews E K, Dean P M, Sakamoto Y (1973) Biophysical effects of sulfonylurea on islet cells. In: Okita G T, Acheson G M (eds) Pharmacology and the future of man: Proc. 5th Int. Congr. Pharmacology. Vol. 3: Problems of therapy. Karger, Basel, p 221–229
Meissner H P, Atwater I J (1976) The kinetics of electrical activity of beta cells in response to a “square wave” stimulation with glucose or glibenclamide. Horm Metab Res 8: 11–16
Meissner H P (1976) Electrical characteristics of the beta cells in pancreatic islets. J Physiol (Paris) 72: 757–767
Curry D L, Bennett L L, Grodsky G M (1968) Requirement for calcium ion in insulin secretion by the perfused rat pancreas. Am J Physiol 214: 174–178
Malaisse W J, Devis G, Pipeleers D G, Somers G (1976) Calcium-antagonists and islet function. IV. Effect of D 600. Diabetologia 12: 77–81
Malaisse W J, Mahy M, Brisson G R, Malaisse-Lagae F (1972) The stimulus-secretion coupling of glucose-induced insulin release. VIII. Combined effects of glucose and sulfonylureas. Eur J Clin Invest 2: 85–90
Hellman B, Lenzen S, Sehlin J, Täljedal I-B (1977) Effects of various modifiers of insulin release on the lanthanum-nondisplaceable 45Ca2+ uptake by isolated pancreatic islets. Diabetologia 13: 49–53
Baker P F, Meves H, Ridgway E B (1973) Calcium entry in response to maintained depolarization of squid axons. J Physiol (Lond) 231: 527–548
Hellman B (1974) Factors affecting the uptake of glibenclamide in microdissected pancreatic islets rich in β cells. Pharmacology 11: 257–267
Henquin J C, Lambert A E (1976) Insulin secretion during B cell depolarization with potassium (Abstract). Diabetes 25 (Suppl 1): 345
Henquin J C (1978) Relative importance of extracellular and intracellular calcium for the two phases of glucose-stimulated insulin release: studies with theophylline. Endocrinology 102: 723–730
Charles M A, Lawecki J, Steiner A L, Grodsky G M (1976) Cyclic nucleotides in pancreatic islets. Tolbutamide and arginine-induced insulin release. Diabetes 25: 256–259
Grill V, Cerasi E (1978) Interacting effects of sulfonylureas and glucose on cyclic AMP metabolism and insulin release in pancreatic islets of the rat. J Clin Invest 61: 1346–1354
Sams D J, Montague W (1972) The role of adenosine 3′, 5′-monophosphate in the regulation of insulin release. Properties of islet-cell adenosine 3′,-5′cyclic monophosphate phosphodiesterase. Biochem J 129: 945–952
Ashcroft S J H, Randle P J, Täljedal I-B (1972) Cyclic nucleotide phosphodiesterase activity in normal mouse pancreatic islets. FEBS Lett 20: 263–266
Henquin J C, Lambert A E (1974) Cationic environment and dynamics of insulin release. II. Effect of a high concentration of potassium. Diabetes 23: 933–942
Braselton W E, Bransome E D, Huff T A (1977) Measurement of antidiabetic sulfonylureas in serum by gas chromatography with electron-capture detection. Diabetes 26: 50–57
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Henquin, J.C. Tolbutamide stimulation and inhibition of insulin release: Studies of the underlying ionic mechanisms in isolated rat islets. Diabetologia 18, 151–160 (1980). https://doi.org/10.1007/BF00290493
Received:
Revised:
Issue Date:
DOI: https://doi.org/10.1007/BF00290493